title: CSF biomarkers for secondary prevention trials: why markers of amyloid deposition and neurodegeneration are both important.
authors.forename: David M
authors.initials: DM
authors.lastname: Holtzman
mesh_terms: D000544:Alzheimer Disease / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000517:prevention & control; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid*; D015415:Biomarkers / Q000134:cerebrospinal fluid; D006801:Humans; D009410:Nerve Degeneration / Q000134:cerebrospinal fluid* / Q000175:diagnosis; D055502:Secondary Prevention
chemical_list: D016229:Amyloid beta-Peptides; D015415:Biomarkers